- ►diabetesjournals.org [PDF] EA Boland, M Grey, A Oesterle, L Fredrickson, WV … - Diabetes Care, 1999 - Am Diabetes Assoc Continuous subcutaneous insulin infu- sion (CSII) via battery - powe red pumps was introduced
to treat type 1 diabetes 20 years ago (1,2). Although this appro ach to insulin replacement provided
a closer app roximation of normal plasma insulin p ro files and increased flexibility re ga ... Cited by 384 - Related articles - BL Direct - All 6 versions
BW Bode, RD Steed, PC Davidson - Diabetes Care, 1996 - Am Diabetes Assoc OBJECTIVE: To compare the incidence of severe hypoglycemia in patients crossed over from
multiple daily injections (MDIs) of insulin to continuous subcutaneous insulin infusion (CSII).
RESEARCH DESIGN AND METHODS: From a population of 225 patients using CSII, all ... Cited by 252 - Related articles - BL Direct - All 5 versions
AK Maniatis, GJ Klingensmith, RH Slover, CJ Mowry, … - Pediatrics, 2001 - Am Acad Pediatrics Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit
Add to Technorati Add to Twitter What's this? ... From the Barbara Davis Center for Childhood
Diabetes, University of Colorado Health Sciences Center, Denver, Colorado. Cited by 143 - Related articles - All 5 versions
- ►angrylapdog.com J Weissberg-Benchell, J Antisdel- … - Diabetes …, 2003 - care.diabetesjournals.org.p. … RESEARCH DESIGN AND METHODS—Studies were identified and data regarding study
design, year of publication, sample size, patient's age, diabetes duration, and duration of CSII
therapy were collected. Means and SDs for glycohemoglobin, blood glucose, insulin ... Cited by 295 - Related articles - BL Direct - All 14 versions
- ►input.me.uk [PDF] N Weintrob, H Benzaquen, A Galatzer, S Shalitin, L … - Pediatrics, 2003 - Am Acad Pediatrics Results. The changes in HbA 1c and fructoseamine values were similar in the 2 arms over
time. At the end of the study, mean HbA 1c level measured 8.05 ± 0.78%. There were no differences
between the treatment modes in frequency of symptomatic hypoglycemic or ... Cited by 135 - Related articles - BL Direct - All 7 versions
JAH Ahern, EA Boland, R Doane, JJ Ahern, P … - Pediatric …, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 127 - Related articles - BL Direct - All 3 versions
- ►bmj.com J Pickup, M Mattock, S Kerry - British Medical Journal, 2002 - bmj.com Continuous subcutaneous insulin infusion, often called insulin pump therapy, was introduced
in the 1970s as a way of achieving and maintaining strict control of blood glucose concentrations
in people with type 1 (insulin dependent) diabetes. 1 Short acting insulin is infused ... Cited by 257 - Related articles - BL Direct - All 10 versions
J Pickup, H Keen - Diabetes care, 2002 - Am Diabetes Assoc Continuous subcutaneous insulin infusion (CSII) is used in selected type 1 diabetic subjects
to achieve strict blood glucose control. A quarter of a century after its introduction, world-wide
use of CSII is increasing. We review the evidence base that justifies this increase, ... Cited by 225 - Related articles - BL Direct - All 8 versions
DM Wilson, BA Buckingham, EL … - Diabetes …, 2005 - care.diabetesjournals.org.p. … RESULTS—The 19 subjects' ages ranged from 1.7 to 6.1 (mean 3.6) years, duration of diabetes
ranged from 0.6 to 2.6 (mean 1.4) years, and baseline HbA 1c ranged from 6.7 to 9.6% (mean
7.9%). Seven subjects were male. Nine subjects were randomized to start CSII and 10 to ... Cited by 109 - Related articles - All 7 versions
